ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "risk assessment"

  • Abstract Number: 1093 • ACR Convergence 2025

    Rituximab Associated Risk for Progressive Multifocal Leukoencephalopathy Among Patients with Systemic Lupus Erythematosus: A Retrospective Cohort Study

    Blake Baay1, Lorien Nassi2 and Zachary Most3, 1Scottish Rite for Children, Dallas, TX, 2UT Southwestern, Children's Medical Center, and Scottish Rite for Children, Dallas, TX, 3UT Southwestern, Dallas, TX

    Background/Purpose: Rituximab is one of the many immunosuppressive medications used to treat SLE that can increase a patient’s risk for developing progressive multifocal leukoencephalopathy (PML),…
  • Abstract Number: 0264 • ACR Convergence 2025

    Seeing Beyond the Eye: Subclinical Audio-Vestibular Involvement in Vogt-Koyanagi-Harada Disease

    Mohamed Tharwat Hegazy, Rania Yacoub, Sarah Sheta, Rana Hussein Amin and Noha Khalil, Faculty of Medicine, Cairo University, Cairo, Egypt

    Background/Purpose: Vogt-Koyanagi-Harada disease (VKH) is a systemic disease that affects the central nervous system, ocular, and integumentary system. It causes bilateral granulomatous uveitis, dysacusia ranging…
  • Abstract Number: 2658 • ACR Convergence 2025

    Risk of Immune-Mediated Inflammatory Diseases and Other Safety Outcomes in Patients with T2DM and Obesity Initiating GLP-1 RA: A Propensity Score-Matched Multi-center Study using the TriNetX Global Network

    Hsin-Hua Chen and Wen-Cheng Chao, Taichung Veterans General Hospital, Taichung, Taiwan (Republic of China)

    Background/Purpose: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for type 2 diabetes mellitus (T2DM) and obesity due to their beneficial metabolic effects. However,…
  • Abstract Number: 1975 • ACR Convergence 2025

    Baseline QTc Screening and Monitoring Among SARD Patients with High Cardiovascular Risks on Hydroxychloroquine Based on 2021 ACR Consensus: A Quality Improvement Project

    Cristine Kuzhuppilly Arcilla1, Gabriel Kirsch2, Gurjit Kaeley3 and Myint Thway4, 1University of Florida Jacksonville, Jacksonville, FL, 2University of Florida - Jacksonville, Jacksonville, FL, 3UF COM-J, Ponte Vedra Beach, FL, 4UF Jacksonville, ponte vedra, FL

    Background/Purpose: In 2017, FDA approved warnings regarding fatal cardiac effects such as cardiomyopathy, torsades de pointes, and QTc prolongation related to both acute and chronic…
  • Abstract Number: 1090 • ACR Convergence 2025

    Quantitative Immunoglobulin Screening Prior to Rituximab Initiation: A Retrospective Cohort Study

    Amelia Khoo and Anokhi Saklecha, Yale University, New Haven, CT

    Background/Purpose: Rituximab, a monoclonal antibody which binds to the CD20 antigen of B cells, is used in the treatment of many rheumatologic conditions. Due to…
  • Abstract Number: 0230 • ACR Convergence 2025

    An Epic journey – Therapeutic Drug Monitoring at an Academic Center

    Puja Khanna1 and Michael Rice2, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Division of Gastroenterology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Non-oncologic use of immunomodulatory agents is increasing. These drugs have a narrow, patient-specific therapeutic index, making therapeutic drug monitoring essential for safe prescribing. However,…
  • Abstract Number: 2633 • ACR Convergence 2025

    Comparative 3-year Safety Outcomes in Patients with Ankylosing Spondylitis Initiating JAK Inhibitor or TNF Inhibitor Therapy

    Hsin-Hua Chen, Taichung Veterans General Hospital, Taichung, Taiwan (Republic of China)

    Background/Purpose: To compare safety outcomes in patients with ankylosing spondylitis (AS) initiating Janus kinase inhibitors (JAKi) versus tumor necrosis factor inhibitors (TNFi).Methods: This retrospective cohort…
  • Abstract Number: 1953 • ACR Convergence 2025

    Machine Learning-Based Classification of Raynaud’s Phenomenon and Autoimmune Diseases in Indeterminate Capillaroscopic Patterns

    Genessis Maldonado1, Adela Marin Ballve2, Luis Sáez Comet3, Mayka Freire Dapena4, Miguel Antonio Mesa5, Miguel Martín Cascón6, Gema María Lledó Ibáñez7, Elena Martínez Robles8, Begoña Marí-Alfonso9, Alfredo Guillén del Castillo10, Carmen Pilar Simeón Aznar10, Borja del Carmelo Gracia Tello2, Eduardo Ramos ibáñez11 and Tracy Frech12, 1Vanderbilt University Medical Center, Nashville, 2Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 3Hospital Universitario Miguel Servet; Zaragoza, Zaragoza, Spain, 4Hospital Clínico Universitario de Santiago de Compostela, La Coruña, Spain, 5Universidad Pontificia Bolivariana, Medellin, Colombia, 6Hospital General Universitario Morales Meseguer, Murcia, Spain, 7Hospital Clínic de Barcelona, Barcelona, Spain, 8Hospital Universitario La Paz, Madrid, Spain, 9Hospital Universitario Parc Taulí, Barcelona, Spain, 10Hospital Universitario Vall D´Hebron, Barcelona, Spain, 11Capillary.io, Zaragoza, Aragon, Spain, 12Vanderbilt University Medical Center, Nashville, TN

    Background/Purpose: Artificial intelligence (AI) has increasingly been integrated into the analysis of nailfold capillaroscopy (NFC), offering new opportunities to automate image interpretation and enhance diagnostic…
  • Abstract Number: 1070 • ACR Convergence 2025

    Cervical Cancer and HPV Screening in Women with Lupus vs Healthy Control Group: A Retrospective Study at a Tertiary Referral Center

    Mahnoor Javed1, Deepak Jagannath2, Alma Aveytia Camacho3, Alwyn Mathew3, Konrad Harms3, Soudabeh Daliri3 and Myriam Guevara4, 1Houston Methodist, Richmond, TX, 2Houston Methodist Hospital, Sugar Land, TX, 3Houston Methodist, Houston, 4Houston Methodist, Houston, TX

    Background/Purpose: Women with SLE are at an increased risk of developing cervical cancer, primarily by human papillomavirus (HPV) and immunosuppression. This elevated risk has been…
  • Abstract Number: 0213 • ACR Convergence 2025

    Development of a Predictive Tool for Obstetric Risk Stratification in Autoimmune Rheumatic Diseases: A Meta-Analysis-Based Model

    Noe Macias-Segura1, Rodolfo Martinez-Canales1, Braulio R. Avalos-Garcia2, Andres M. Ortiz-Rios2, Eva Abigaid Galindo-Calvillo2, Mario Cesar Salinas-Carmona1, Lorena Perez-Barbosa2, Dionicio A. Galarza-Delgado3 and Cassandra Michele Skinner-Taylor2, 1Immunology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 2Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Nuevo Leon, Mexico, 3Rheumatology Service, Hospital Universitario Dr. José Eleuterio González, Universidad Autónoma de Nuevo León, Monterrey, Mexico

    Background/Purpose: Autoimmune rheumatic diseases (ARDs) such as systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), rheumatoid arthritis (RA), and Sjögren's syndrome significantly increase the risk of…
  • Abstract Number: 0469 • ACR Convergence 2024

    SCORE2 Is Superior to SCORE in Predicting the Presence of Carotid Plaques and Intima-media Thickness in Rheumatoid Arthritis Patients: A Cross-sectional Study with Carotid Ultrasound

    Cristina Campos Fernández1, Jorge Juan Fragío Gil2, Roxana González Mazario3, Pablo Martínez Calabuig4, Laura Salvador Maicas5, Mireia Lucía Sanmartín Martínez6, Iván Jesús Lorente Betanzos6, Clara Molina Almela6, juan José Lerma Garrido7, Amalia Rueda3 and Jose A Román-Ivorra8, 1Escuela de Doctorado, Universidad Católica de Valencia San Vicente Mártir, Valencia, Spain, 2Hospital General Universitario, Valencia, Comunidad Valenciana, Spain, 3Hospital General de Valencia, Valencia, Comunidad Valenciana, Spain, 4HOSPITAL GENERAL UNIVERSITARIO VALENCIA SPAIN, Ontinyent, Comunidad Valenciana, Spain, 5Consorcio Hospital General Universitario de Valencia, Castellón de la Plana, Comunidad Valenciana, Spain, 6Consorcio Hospital General Universitario de Valencia, Valencia, Comunidad Valenciana, Spain, 7Hospital General Universitario Valencia, Valencia, Comunidad Valenciana, Spain, 8Hospital Universitari i Politècnic la Fe, Valencia, Comunidad Valenciana, Spain

    Background/Purpose: Rheumatoid arthritis (RA) escalates the risk of premature mortality, predominantly through cardiovascular diseases. Although SCORE and its updated version, SCORE2, are employed to assess…
  • Abstract Number: 1329 • ACR Convergence 2024

    Investigating Predictors of Transfusion in Rheumatoid Arthritis and Osteoarthritis Patients Undergoing Knee Arthroplasty

    Stephen Batter1, Huong Do1, Dongmei Sun2, Ahmed Deeb1, Trang Bui1, Jason Blevins1, Mark Figgie1, Gwo-Chin Lee1, J. Alex B. Gibbons3, Bella Mehta4, Susan Goodman5 and Linda A Russell1, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Birmingham, AL, 3Columbia University Vagelos College of Physicians & Surgeons, New York, NY, 4Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 5Hospital for Special Surgery, New York 10025, NY

    Background/Purpose: Use of ambulatory surgery in arthroplasty is increasing, but the need for transfusion mandates hospital admission. Despite the significant drop in transfusion rate linked…
  • Abstract Number: 2026 • ACR Convergence 2024

    Cardiovascular Risk Measured by PREVENT Calculator and Disease Activity in Patients with Systemic Lupus Erythematosus

    Rebeca L. Polina-Lugo1, Aleydis Gonzalez Melendez1, Maria F. Elizondo-Benitez2, Andrea Guajardo Aldaco1, Annette Dominguez-Guerra3, Victoria P. Limas-Martínez1, Iris Jazmín Colunga Pedraza1, Dionicio Galarza-Delgado4, jose Ramon Azpiri-Lopez5, Rosa Icela Arvizu-Rivera1 and Jesus Cardenas-de la Garza6, 1Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 2Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 3Division of Rheumatology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo León, Mexico, 4UANL Hospital Universitario, Monterrey, Nuevo León, Mexico, 5Division of Cardiology, University Hospital "Dr. Jose Eleuterio Gonzalez", Universidad Autonoma de Nuevo Leon, Monterrey, Mexico, 6Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico

    Background/Purpose: Increased disease activity by SLEDAI (Systemic Erythematosus Lupus Disease Activity Index) has been associated with higher cardiovascular risk (CVR) and atherosclerotic cardiovascular disease (ASCVD),…
  • Abstract Number: 0492 • ACR Convergence 2024

    A Machine Learning Model for the Early Identification of Rheumatoid Arthritis: Development and Validation

    Michael Dreyfuss1, Yonatan Jenudi2, Dan Riesel3, Or Ramni3, Daniel Underberger4, Benjamin Getz5, Shlomit Steinberg-Koch3, Douglas White6 and Elena Myasoedova7, 1Predicta Med, Ramat Gan, Israel, 2[email protected], Ramat Gan, Israel, 3Predicta Med Analytics Ltd., Ramat Gan, Israel, 4Predicta Med Analytics Ltd., Bridgeport, CT, 5CTO, Ramat Gan, Israel, 6Gundersen Health System, Onalaska, WI, 7Mayo Clinic, Rochester, MN

    Background/Purpose: Patients with rheumatoid arthritis often experience clinically significant delays in diagnosis (Sørensen et al., 2015; Raza et al., 2011). RA can present similarly to…
  • Abstract Number: 1334 • ACR Convergence 2024

    Assessing the Performance of Validated Frailty Instruments in Veterans with Rheumatoid Arthritis (RA)

    Kylie Riggles1, Hannah Brubeck2, Riley Bass3, Courtney Loecker4, Punyasha Roul5, Bryant England6, Elizabeth Wahl7, James Andrews8, Namrata Singh9, Joshua Baker10, Patti Katz11, Dolores Shoback12, Jose Garcia13, ariela orkaby14 and Katherine Wysham15, 1VA Puget Sound Health Care System, Bellevue, WA, 2VA Puget Sound Health Care System, Seattle, WA, 3VA Puget Sound Health Care System, Gig Harbor, WA, 4University of Nebraska, Lincoln, NE, 5UNMC, Omaha, NE, 6University of Nebraska Medical Center, Omaha, NE, 7VA Puget Sound Healthcare System, Seattle, WA, 8University of Alabama at Birmingham, Birmingham, AL, 9University of Washington, Bellevue, WA, 10University of Pennsylvania, Philadelphia, PA, 11UCSF, San Rafael, CA, 12San Francisco VA/University of California, San Francisco, San Francisco, CA, 13VA Puget Sound Health Care System/University of Washington, Seattle, WA, 14New England VA Geriatric Research Education and Clinical Center/Boston VA/Division of Aging, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 15VA PUGET SOUND/UNIVERSITY OF WASHINGTON, Seattle, WA

    Background/Purpose: Frailty is a state of decreased physiological reserve that confers an increased vulnerability to stressors and adverse outcomes1. Compared to the general population, frailty…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 16
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology